Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK106191-09
The CD226 costimulatory axis in type 1 diabetes
Recipient
University of Florida
Award Amount
$590,577.00
Ceiling
$590,577.00
Awarded
January 26, 2026
Identifier
5R01DK106191-09
Research grant awarded to study the CD226 costimulatory axis in type 1 diabetes, involving advanced molecular techniques and aiming to develop therapeutic interventions, with funding of about $590,577 for 2026.
Description
This is a research grant opportunity focused on the role of CD226 in type 1 diabetes, with a total award amount of approximately $590,577 for the fiscal year 2026. The project involves advanced molecular and cellular techniques, including spatial transcriptomics, gene editing, and in vivo studies in NOD mice and human tissues. The grant aims to explore immune checkpoint dysregulation and develop potential therapeutic interventions.